NasdaqGM - Nasdaq Real Time Price USD
Castle Biosciences, Inc. (CSTL)
At close: November 15 at 4:00 PM EST
After hours: November 15 at 5:41 PM EST
Research Analysis
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 8 | 6 | 8 | 8 |
| Avg. Estimate | 0.02 | -0.68 | 0.36 | -1.91 |
| Low Estimate | -0.12 | -0.81 | 0.24 | -2.52 |
| High Estimate | 0.14 | -0.53 | 0.56 | -1.1 |
| Year Ago EPS | -0.1 | -0.09 | -2.14 | 0.36 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 9 | 7 | 9 | 9 |
| Avg. Estimate | 80.58M | 59.86M | 326.31M | 265.63M |
| Low Estimate | 75.4M | 56M | 321.1M | 245M |
| High Estimate | 84.49M | 67.72M | 330.25M | 293.18M |
| Year Ago Sales | 66.12M | 72.97M | 219.79M | 326.31M |
| Sales Growth (year/est) | 21.86% | -17.97% | 48.47% | -18.60% |
Earnings History
| CURRENCY IN USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | -0.49 | -0.31 | -0.25 | 0.01 |
| EPS Actual | -0.1 | -0.09 | 0.31 | 0.08 |
| Difference | 0.39 | 0.22 | 0.55 | 0.07 |
| Surprise % | 79.71% | 71.20% | 226.53% | 966.67% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0.02 | -0.68 | 0.36 | -1.91 |
| 7 Days Ago | -0.74 | -0.75 | -0.52 | -2.26 |
| 30 Days Ago | -0.74 | -0.75 | -0.52 | -2.25 |
| 60 Days Ago | -0.74 | -0.75 | -0.52 | -2.25 |
| 90 Days Ago | -0.72 | -0.74 | -0.52 | -2.23 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 6 | 4 | 6 | 6 |
| Up Last 30 Days | 6 | 4 | 6 | 6 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | CSTL | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 116.25% | -- | -- | 5.00% |
| Next Qtr. | -657.41% | -- | -- | 12.00% |
| Current Year | 116.94% | -- | -- | 2.10% |
| Next Year | -628.28% | -- | -- | 12.20% |
Upgrades & Downgrades
| Maintains | Scotiabank: Sector Outperform to Sector Outperform | 11/6/2024 |
| Maintains | Lake Street: Buy to Buy | 11/5/2024 |
| Maintains | Keybanc: Overweight to Overweight | 11/5/2024 |
| Maintains | Baird: Outperform to Outperform | 11/5/2024 |
| Maintains | Canaccord Genuity: Buy to Buy | 10/29/2024 |
| Maintains | BTIG: Buy to Buy | 10/14/2024 |
Related Tickers
CDNA CareDx, Inc
21.17
-1.76%
VCYT Veracyte, Inc.
35.94
-2.97%
MYGN Myriad Genetics, Inc.
15.25
-2.74%
FLGT Fulgent Genetics, Inc.
17.31
-2.70%
GH Guardant Health, Inc.
29.11
-3.64%
EXAS Exact Sciences Corporation
49.33
-3.14%
NEO NeoGenomics, Inc.
15.04
-4.75%
TWST Twist Bioscience Corporation
36.89
-5.31%
PSNL Personalis, Inc.
3.8900
-9.53%
NOTV Inotiv, Inc.
2.6800
-1.83%